




1078–5884/00Single Center Experience with a New Commercially
Available Thoracic Endovascular Graft
G. Melissano,* E. Civilini, M.R.L. de Moura, F. Calliari and R. ChiesaDepartment of Vascular Surgery, ‘Vita-Salute’ University, Scientific Institute H. San Raffaele, Milan, ItalyPurpose. To evaluate the intra-operative performance and clinical outcome of a new commercially available stent-graft for
the treatment of thoracic aortic diseases.
Methods and patients. From January 2003 to October 2004, 45 consecutive patients received endovascular treatment with the
Zenith TX1 device for diseases of the thoracic aorta at a single center in northern Italy. Indications included disease of the
descending thoracic aorta in 26 cases, of the aortic arch in 17 cases and of the thoraco-abdominal aorta in two cases. We treated 38
atherosclerotic aneurysms, two post-traumatic aortic ruptures, two penetrating ulcers, two chronic dissections and one case was
treated for aortic bleeding after voluntary acid ingestion for attempted suicide. General anesthesia was used in 20 cases. Combined
or hybrid endovascular and open surgical repair was performed in 11 patients. Mean follow-up was 7 months (range 1–22 months).
Results. Technical success was obtained in 44 patients (98%). One primary type I endoleak occurred (2%). ICU was used in
12 cases with a mean stay of 1 day. The mean hospital stay was 6 days (range 4–13 days). There were no hospital deaths or
strokes but one transient paraplegia (2%). A type II endoleak was observed in one case and resolved spontaneously 1 month
later. No aneurysm enlargement, endograft migration or structural failures were observed during follow-up. Two late
unrelated-deaths were observed.
Conclusions. This stent-graft does not fulfill all the characteristics of the ideal graft, however, it proved to be safe and
allowed satisfactory short term results in this group of patients treated at a single center.Keywords: Aortic aneurysm; Thoracic aorta; Stent-graft; Endovascular.Introduction
Few mid and long term studies on the outcome of
endovascular grafting of the thoracic aorta have been
reported. However, this procedure is becoming more
popular for the treatment of a wide range of diseases
due to its reduced invasivity especially in patients at
increased risk for open surgery.1–5 Several factors
correlate with the final outcome of the procedure
including the type of disease, its extension and
anatomical characteristics, the age and co-morbidities
of the patient,6 the type of endovascular graft and the
experience of the individual and of the center
performing the procedure.
Since, the introduction of endovascular grafting of
the thoracic aorta by the Stanford group a decade ago7,
8 several custom made and commercially available
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technological improvements the currently available
grafts are still relatively primitive since they require
large introducer sheaths, they are stiff and navigate
poorly through the iliac and aortic tortuousities;9
oversizing and radial force that are necessary for
sealing may damage the aortic wall. Moreover, the
durability over time of both the metal and the fabric
components of the grafts is a major concern. The
purpose of this study was to evaluate a new
commercially available stent-graft for the treatment
of thoracic aortic diseases. The intra-operative per-
formance and clinical outcome were analyzed in a
series of 45 patients treated in a single center in
northern Italy during 2 years.Materials and MethodsPatient population
From January 2003 to October 2004, 45 consecutiveEur J Vasc Endovasc Surg 29, 579–585 (2005)
doi:10.1016/j.ejvs.2005.01.018, available online at http://www.sciencedirect.com onved.
G. Melissano et al.580patients received endovascular treatment for diseases
of the thoracic aorta at our institution. Written
informed consent was obtained in all cases. This series
included 40 males and five females with a mean age of
73 years (range 19–86 years). Indications for treatment
included disease of the descending thoracic aorta in 26
cases, of the aortic arch in 17 cases and of thoraco-
abdominal aorta in two cases. Atherosclerotic aneur-
ysms were observed in 38 cases, penetrating ulcers in
two cases, chronic dissections in two cases, post-
traumatic aortic rupture in two cases and one patient
had esophageal, gastric and aortic injuries after
ingestion of muriatic acid (27% HCl), attempting
suicide. Acute dissections were not treated with this
device, as advised by the manufacturer, due to the
presence of a distal bare stent and proximal and distal
barbs for anchoring. One patient was treated emer-
gently for traumatic rupture of the aortic isthmus after
a motor vehicle accident; the other patients were
treated electively.Procedures
Graft oversizing 10–20% in diameter was based on
pre-operative spiral-CT scans (slice thickness: 0.5–
2 mm); aortogram with calibrated catheters were also
obtained selectively (28 cases) in patients with com-
plex pathology, severe aortic tortuosity or involvement
of supra-aortic or visceral vessels. All the patients
underwent pre-operative ilio-femoral and carotid
artery duplex ultrasound.
The common femoral artery was used for device
insertion in 40 cases (88.9%), a retroperitoneal iliac
approach was used in two patients (Fig. 1) and three
patients had the device inserted through an infra-renal
aortic tube graft.
Spinal anesthesia was used in 22 cases, localFig. 1. Device insertion through common iliac artery by
means of a retroperitoneal approach.
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cases. All the procedures were performed in the
operating room, using a portable digital C-arm
image intensifier with subtraction angiography and
road-mapping capabilities (SIMAD Medical Technol-
ogy, Modena, Italy). Trans-esophageal echocardiogra-
phy (TEE) was used in six selected cases (13.6%). The
contrast agent used was ioprimide (Ultravist,
300 mg/ml, Berlin, Germany) and the mean volume
given during procedure was 156G58 ml (range 60–
370 ml). The mean time of fluoroscopy utilized was
21 min (range 5–46 min) and procedures had a mean
duration of 74 min (range 42–220 min). Three patients
required packed red blood cells transfusion, and the
mean volume of bleeding during the procedures was
170 ml (range 110–1150 ml).
Combined or hybrid endovascular and open surgi-
cal repair was performed in 11 patients, by means of
staged or simultaneous procedures. In nine cases,
surgical revascularization of the supra-aortic trunks or
abdominal visceral arteries was performed to obtain a
neck of suitable length (de-branching of the aorta). The
other two underwent combined treatment of a
descending aortic and infrarenal abdominal aortic
aneurysms. The left subclavian artery was covered in
nine cases with no additional revascularization pro-
cedure necessary. In another patient with previous
myocardial revascularization by mean of a left internal
thoracic artery to left anterior descending artery, a
carotid to subclavian bypass was performed before
covering the subclavian artery.
Follow-up ranged from 1 to 22 months (mean 7.3)
and was obtained in all patients. This was achieved
with CT and chest X-ray controls every 6 months for 1
year, and then yearly.Endovascular prosthesis
All patients were treated with the Zenith TX1 device
(William Cook Europe—Denmark), which obtained
the CE marking in April 2001 and is available for
clinical use in Europe. The endograft consists of self-
expandable stainless steel Gianturcow Z-stents and
woven polyester fabric (Dacronw). An uncovered Z-
stent with hooks is located at the bottom of the graft
body for fixation, contained in a capsule that protects
the sheath from the cranially orientated hooks during
sheath withdrawal. The first proximal covered stent
also has hooks. These hooks will go through the wall of
the aorta thus stabilizing the graft.10 The gaps between
stents vary from 5 to 10 mm depending on the
diameter of the graft. The graft has four proximal
and distal radiopaque gold markings for better
Novel Endograft for Thoracic Aorta 581location in the vessel and an additional marker on each
stent for visualization of twists during placement.
The introduction system has a long tapered tip that
may be either straight for delivery in the descending
thoracic aorta or curved for delivery in the aortic arch.
The tapered tips may be 8 or 10 cm long. Shorter tips are
available in custom-made devices. Endograft diameters
available range from 22 to 42 mm, which need an 18–
22 Fr diameter introduction system to be inserted.
Deployment requires several steps: first the introducer
sheath is withdrawn at this stage, however, the top of the
proximal stent is still held closed by a wire, thus
avoiding a parachute effect in the aortic bloodstream.
The bottom-uncovered stent is also still closed, housed
within a bottom cap that protects the sheath from the
cranially orientated barbs during sheath withdrawal.
The wires connected to the top and bottom stents need to
be pulled out sequentially in order to release the stents
and fully deploy the graft, the distal bare stent is released
first and the proximal stent, last.Technical details
Patients were placed in the dorsal decubitus position,
and the operative field was prepared and draped
permitting emergency laparotomy or thoracotomy.
Cerebrospinal fluid drainage was used in six selected
cases. All patients received prophylactic antibiotic
therapy peri-operatively. In most cases, the common
femoral artery was exposed through an inguinal
incision. A bolus of heparin (70 IU/kg) was adminis-
tered. The contra-lateral femoral artery was percuta-
neously punctured for diagnostic aortography. A stiff
260-cm-long, 0.035-inch guide wire (Lunderquist,
William Cook Europe—Denmark or Amplatz, Boston
Scientific Corporation, Miami, FL) or a 300-cm-long,
0.035-inch super-stiff guide wire (Back-up-Meier,
Boston Scientific, Medi-Tech, Miami, USA) was
advanced up to the aortic arch under fluoroscopic
guidance. The stent-graft was then passed over the
guide wire into the appropriate position within the
descending thoracic aorta or aortic arch under fluoro-
scopic guidance. Additional left brachial arterial
access was used in five cases. During deployment a
mild systemic hypotension was induced pharmaco-
logically by the anesthesiologist with a bolus of fast-
acting venous or arterial vasodilators such nitrates or
urapidil. Nitroprusside or adenosine-induced asystole
were never used. After deployment of the endoprosth-
esis in the selected location a completion angiogram
was performed. Ballooning of the stent graft proxi-
mally and distally was only required in one patient in
this series.Results
Technical success11 was obtained in 44 cases (97.8%),
with one (2.2%) primary endoleak discovered at the
time of intra-operative completion aortography that
was left untreated because the proximal aortic neck
was inadequate for further endovascular procedures.
Diameter of the grafts used ranged from 26 to 42 mm
(mean 37 mm) and length from 100 to 230 mm (mean
143 mm). All the prosthesis were standard tubular
endografts except for one custom-made endograft
used to treat an aortic arch aneurysm.
ICU was required in 12 cases (patients that received
a hybrid surgical-endovascular approach, one case of
severe coronary artery disease) with a mean stay of 1
day. The mean hospital stay was 6 days (range 4–13
days). We recorded one case of transient paraplegia, no
hospital deaths or strokes. Post-operative fever, leu-
kocytosis, elevated CRP occurred in 14 cases and
resolved in a mean of 2.5G1 days. The patient
undergoing complete aortic arch grafting experienced
an asystolic cardiac arrest during surgery. Cardiac
resuscitation was immediately performed by means of
direct cardiac massage and intravenous adminis-
tration of 2 mg of adrenaline. Spontaneous and
effective cardiac activity was promptly restored and
the procedure was completed uneventfully. The same
patient experienced atrial fibrillation and pulmonary
effusion, respectively, on post-operative days 2 and 3,
which regressed after medical therapy. Neither arterial
thromboembolism nor other cardiac, renal and major
respiratory problems were recorded in the remaining
patients in the early post-operative period. In the nine
cases, in which the left subclavian artery was covered
no clinically relevant adverse consequence was
observed.
Post-operative CT scans were obtained in 44
patients and complete thrombosis was observed in
all but one of the aneurysms. In one patient with renal
failure post-operative thrombosis of the sac was
ascertained by means of TEE. A type II endoleak was
observed in one case and resolved spontaneously with
aneurysmal sac thrombosis seen with CT scan 1 month
later. Mean follow-up was 7.3 months (range 1–22) and
two late unrelated-deaths were recorded. Aneurysm
enlargement, endograft migration or structural fail-
ures were also not observed.Discussion
Mortality and morbidity rates of thoracic aorta open
repair are currently still significant in spite of the
anesthesiological and technical progress made in thisEur J Vasc Endovasc Surg Vol 29, June 2005
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accepted for treating a selected population of patients
with thoracic aortic pathology, mainly due to its
reduced invasiveness.8,13–16 Patients who require
treatment are frequently elderly and have important
associated co-morbidities (cardiac, respiratory, cere-
bro-vascular and renal diseases).17 An endovascular
approach to the descending aorta can be performed
under loco-regional anesthesia,18 and avoids aortic
clamping and its well-known haemodinamic and
ischemic complications.19,20
On the other hand, in the long term, the safety and
durability of the stent grafts are not clear, and also
changes of aneurysm dimensions and morphology can
happen. In particular, prospective studies in this field
are still lacking.21 Several thoracic endografts are now
available commercially, each with its own
peculiarities, advantages and drawbacks. The Talent
graft for instance is one of the most popular ones,
however, ready-made grafts come in one length
(115 mm) only. Due to the friction of the stents with
the sheath, difficulties have been described when
trying to release in angulated areas or in the arch.6 The
endograft proximal stent is opened first during the
deployment phase, which can cause a ‘parachute
effect’. The Excluder TAG graft has also been used
worldwide with successful short-term results until
November 2001; a new modified device without the
longitudinal spines is now available for clinical use.
This graft characteristically opens up almost instantly,
the parachute effect is thus avoided, however, it cannot
be positioned in an extremely precise fashion. Endofit
graft was recently modified both in terms of the stent
graft and the delivery system. We recently describedFig. 2. The stent-graft system shows good flexibility and
appears suitable to treat aortic arch pathologies. Of note the
proximal covered stent with the hooks facing downwards,
and the distal uncovered stent with the hooks facing
upwards designed in order to prevent migration.
Eur J Vasc Endovasc Surg Vol 29, June 2005our experience with their first generation device for
the treatment of thoracic aortic pathology.22
Several literature reports have pointed out that
serious and even fatal problems may arise from
introduction of the device through the femoral artery.
In particular, rupture or avulsion of the external iliac
artery have been reported frequently.5,9,21,23 We, there-
fore, liberally switch to extraperitoneal surgical
exposure of the common iliac artery or even the distal
aorta if it is difficult to advance the device through the
femoral arteries. We have found it unnecessary to
anastomose a vascular graft on the vessel to facilitate
introduction, as we did previously. A simple purse-
string suture on Teflon pledgets is enough to guaran-
tee hemostasis (Fig. 1). Tunneling of the sheath
through the fascia and skin may avoid further
tortuousity and kinks.
In this series, deployment at the intended position
was possible in all cases. The endograft has very good
visibility and trackability even considering the lower
imaging quality that is obtained with a portable C-arm
as compared with fixed equipments. Control during
deployment is satisfactory since the graft is still held
by the introduction system after withdrawal of the
sheath. The graft system is highly flexible (Fig. 2),
however, this is not the case with the introducer sheath
which is relatively stiff and tends to kink in tortuous
segments, therefore, sheath withdrawal may require a
significant amount of force especially when the graft is
delivered in the aortic arch or through an angled route.
We have found that warming the tapered dilator tip
with hot saline, just prior to insertion, makes it softer
and helps the introducer navigate the tortuousities.
The rationale for applying downward oriented hooks
in the proximal stent and upwards oriented hooks in
the distal one, is to avoid the proximal stent being
pulled downwards and the distal stent being pulled
upwards by the vector forces of the blood column
flowing into the descending aorta.24,25 Earlier exper-
imental experiences have shown that the displacement
force needed to dislodge a graft from the aorta in the
Zenith design with hooks that penetrate the aortic wall
without damaging it, is significantly higher than with
other stent-grafts (Talent, Vanguard, Ancure). A
sutured graft-aorta anastomosis, however, was six
times stronger.26 Migration was never a problem in
our series.
Guide wire and catheter manipulation as well as
navigation of the introducer through diseased vessels,
especially at the level of the supra-aortic trunks, may
be responsible for distal embolization and cerebrovas-
cular accidents.27 They should be kept at a minimum
and the technique should be meticulous. Earlier
experience with trans-ostial placement of stainless
Fig. 3. (a) Schematic view of a complex TAAA with previous thoracic and infrarenal aortic tube-graft replacement. Note the
retrograde bifurcated bypass to visceral arteries. (b) Intra-operative angiogram after endograft deployment showing patency
of visceral branches. (c) Post-operative CT-scan evidencing complete thrombosis of the thoracoabdominal aneurysm.
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fairly confident with placement of the bare stent at this
level.28–34
Hybrid approaches for arch and thoracoabdominal
aortic aneurysms may extend the applicability of
endovascular procedures in these delicate anatomical
regions.35–37 We treated three very ill patients, unfit for
traditional surgery, with hybrid endovascular pro-
cedures, avoiding more invasive open surgery
approaches. Two cases of arch aneurysms were treated
with previous supra-aortic trunk revascularization. In
the first patient, a right common to left common carotid
extra-thoracic bypass was performed. In the second one,
after a median sternotomy, the ascending aorta was side-
clamped, then a bifurcated bypass was performed to the
innominate artery and left common carotid. The third
patient submitted to the hybrid approach had a
thoracoabdominal aortic aneurysm (TAAA), a frozen
chest from previous thoracic aneurysm resection and a
previous abdominal infrarenal aneurysm resection for
rupture. A retrograde bifurcated bypass graft from the
abdominal aortic graft to the visceral arteries (SMA and
CT) was performed (Fig. 3). An endovascular exclusion
of the TAAA extending from the mid-thoracic graft to
the suprarenal aorta was then performed.
A single-stage open surgical repair for thoracic and
abdominal aortic aneurysms is a subject of much
controversy due to the increased surgical time and
associated risks.38 We treated two patients with
combined open surgical and endovascular repair of
infrarenal and a descending thoracic aneurysms. In
both cases, the device was inserted through the infra-
renal aortic graft, and the patients did well in the post-
operative period.
Another topic of concern is precise endograft
deployment, necessary when the proximal or distal
aneurysm neck is near the supra-aortic vessels or
abdominal visceral arteries. In one case, the celiac
trunk was covered by the distal bare stent. Selective
catheterization was used to identify the exact visceral
artery location during deployment. The celiac trunk
inflow was not affected by the partial ostial covering,
as showed on the post-operative CT-scan. The bottom
stent of this prosthesis may be very helpful for treating
descending aortic pathology with short distal neck.
Two cases in this series were treated for acute post-
traumatic thoracic aortic rupture. The current experi-
ence with endovascular treatment of traumatic lesions
is increasing and a few cases have been described in
the literature.39–43 More debatable44 is the indication
for another case of a young man that attempted suicide
ingesting a large quantity of muriatic acid. He under-
went two previous open procedures: a subtotal
esophago-gastrectomy and total gastrectomy withEur J Vasc Endovasc Surg Vol 29, June 2005repair of aorto-esophageal fistula. He experienced
recurrent aortic bleeding on 28th post-operative day,
which was treated with endovascular deployment of
the stent-graft into the supra-celiac aorta.
Endovascular thoracic stent-grafting avoids spinal
cord ischemia due to aortic cross-clamping, but
presents a risk of spinal cord injury due to occlusion
of critical intercostal arteries covered by the endograft.
In some cases, especially for lengthy aneurysms or in
patients with previous aortic surgery, the blood supply
to the spinal cord through collaterals may be severely
affected, leading to ischemic complications.45 Rec-
ommendations for routine prophylactic use of CSF
drainage during thoracic or thoracoabdominal aortic
reconstruction have been conflicting and procedure-
related complication are described.46 Nonetheless
many other reports describe the benefits of CSF
drainage, sometimes in combination with systemic or
intrathecal drugs, and the outcome in our experience
of endovascular TAA repair supports the potential
therapeutic role of this manoeuvre.47,48 In conclusion,
this stent graft proved to be safe and allowed
satisfactory short term results in this group of patients
treated at a single centre, including a number of cases
with disease of the aortic arch.References
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